Quick Answer
Maze Therapeutics, Inc. reported Total Assets of $397.13 million for the year ending 2025.
- Maze Therapeutics, Inc. showed an increase of +65.1% in Total Assets from 2024 to 2025.
- This data is from Maze Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 25, 2026.
- XBRL data for this metric is available from 2024 to 2025 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2025: $332.84 million | Q2 2025: $303.52 million | Q3 2025: $422.06 million.
- Historical annual values: Fiscal year 2025: $397.13 million | Fiscal year 2024: $240.54 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: